JG-2016
JG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1) with an IC50 of 14.8 μM. JG-2016 can inhibit the growth of multiple tumor cells and has anti-tumor activity[1].
Product Specifications
CAS Number
[2887480-87-5]
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jg-2016.html
Purity
98.44
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1)N=C2N(CCOCC(C)C)C3=CC(CC)=C(Cl)C=C3N=C2C1=O
Molecular Formula
C18H21ClN4O3
Molecular Weight
376.84
References & Citations
[1]Joshua James GRUBER, et al. Modulators of histone acetyltransferase 1 and methods of treatment thereof. Patent, WO2022272313A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2269-02H 250 µg
CD18 (Beta 2 Antigen CD18 (p95), Cell Surface Adhesion Glycoproteins LFA 1/CR3/p150 95 beta Subunit, Complement Receptor C3 beta Subunit, Integrin beta 2, ITGB2, LAD, LCAMB, Leukocyte Cell Adhesion Molecule CD18, LFA1, Lymphocyte Function Associated Antigen 1, Macrophage Antigen 1 (mac1) beta Subunit, MF17) discontinued
Ask
View Details AM20642PU-N 100 µg
Myosin Heavy chain 1 (MYH1) (fast) Mouse Monoclonal Antibody [Clone ID: MY-38]
Ask
View Details 
